Literature DB >> 11907245

Mutations that confer resistance to template-analog inhibitors of human immunodeficiency virus (HIV) type 1 reverse transcriptase lead to severe defects in HIV replication.

Timothy S Fisher1, Pheroze Joshi, Vinayaka R Prasad.   

Abstract

We isolated two template analog reverse transcriptase (RT) inhibitor-resistant mutants of human immunodeficiency virus (HIV) type 1 RT by using the DNA aptamer, RT1t49. The mutations associated, N255D or N265D, displayed low-level resistance to RT1t49, while high-level resistance could be observed when both mutations were present (Dbl). Molecular clones of HIV that contained the mutations produced replication-defective virions. All three RT mutants displayed severe processivity defects. Thus, while biochemical resistance to the DNA aptamer RT1t49 can be generated in vitro via multiple mutations, the overlap between the aptamer- and template-primer-binding pockets favors mutations that also affect the RT-template-primer interaction. Therefore, viruses with such mutations are replication defective. Potent inhibition and a built-in mechanism to render aptamer-resistant viruses replication defective make this an attractive class of inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907245      PMCID: PMC136095          DOI: 10.1128/jvi.76.8.4068-4072.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Selection of high-affinity RNA ligands to reverse transcriptase: inhibition of cDNA synthesis and RNase H activity.

Authors:  H Chen; L Gold
Journal:  Biochemistry       Date:  1994-07-26       Impact factor: 3.162

2.  Subunit-selective mutagenesis of Glu-89 residue in human immunodeficiency virus reverse transcriptase. Contribution of p66 and p51 subunits to nucleoside analog sensitivity, divalent cation preference, and steady state kinetic properties.

Authors:  Y Kew; S Qingbin; V R Prasad
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

3.  Reduced frameshift fidelity and processivity of HIV-1 reverse transcriptase mutants containing alanine substitutions in helix H of the thumb subdomain.

Authors:  K Bebenek; W A Beard; J R Casas-Finet; H R Kim; T A Darden; S H Wilson; T A Kunkel
Journal:  J Biol Chem       Date:  1995-08-18       Impact factor: 5.157

4.  High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus.

Authors:  D J Schneider; J Feigon; Z Hostomsky; L Gold
Journal:  Biochemistry       Date:  1995-07-25       Impact factor: 3.162

5.  A novel in situ colony screening method to detect human immunodeficiency virus reverse transcriptase activity expressed in bacteria. Isolation of pseudorevertants of reverse transcriptase mutants.

Authors:  V R Prasad; S P Goff
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

6.  Structural requirements for bacterial expression of stable, enzymatically active fusion proteins containing the human immunodeficiency virus reverse transcriptase.

Authors:  N Tanese; V R Prasad; S P Goff
Journal:  DNA       Date:  1988 Jul-Aug

7.  Characterization of an in vitro-selected RNA ligand to the HIV-1 Rev protein.

Authors:  K B Jensen; L Green; S MacDougal-Waugh; C Tuerk
Journal:  J Mol Biol       Date:  1994-01-07       Impact factor: 5.469

Review 8.  Gene therapy using SV40-derived vectors: what does the future hold?

Authors:  D S Strayer
Journal:  J Cell Physiol       Date:  1999-12       Impact factor: 6.384

9.  Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool.

Authors:  P Allen; S Worland; L Gold
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

10.  Structure/function studies of human immunodeficiency virus type 1 reverse transcriptase. Alanine scanning mutagenesis of an alpha-helix in the thumb subdomain.

Authors:  W A Beard; S J Stahl; H R Kim; K Bebenek; A Kumar; M P Strub; S P Becerra; T A Kunkel; S H Wilson
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

View more
  15 in total

1.  Inhibition of HIV-1 reverse transcriptase by RNA aptamers in Escherichia coli.

Authors:  David G Nickens; James T Patterson; Donald H Burke
Journal:  RNA       Date:  2003-09       Impact factor: 4.942

2.  Novel aptamer inhibitors of human immunodeficiency virus reverse transcriptase.

Authors:  Jeffrey J DeStefano; Gauri R Nair
Journal:  Oligonucleotides       Date:  2008-06

3.  Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.

Authors:  Daniel M Held; Jay D Kissel; Sarah J Thacker; Daniel Michalowski; Dayal Saran; Jianfei Ji; Richard W Hardy; John J Rossi; Donald H Burke
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

4.  Mutations proximal to the minor groove-binding track of human immunodeficiency virus type 1 reverse transcriptase differentially affect utilization of RNA versus DNA as template.

Authors:  Timothy S Fisher; Tom Darden; Vinayaka R Prasad
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.

Authors:  Laurent Chaloin; Maik Jörg Lehmann; Georg Sczakiel; Tobias Restle
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

6.  Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).

Authors:  Pheroze Joshi; Vinayaka R Prasad
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 7.  Aptamers: novel molecules as diagnostic markers in bacterial and viral infections?

Authors:  Flávia M Zimbres; Attila Tárnok; Henning Ulrich; Carsten Wrenger
Journal:  Biomed Res Int       Date:  2013-09-05       Impact factor: 3.411

8.  Novel bimodular DNA aptamers with guanosine quadruplexes inhibit phylogenetically diverse HIV-1 reverse transcriptases.

Authors:  Daniel Michalowski; Rebecca Chitima-Matsiga; Daniel M Held; Donald H Burke
Journal:  Nucleic Acids Res       Date:  2008-11-07       Impact factor: 16.971

9.  Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.

Authors:  Pantxika Bellecave; Christian Cazenave; Julie Rumi; Cathy Staedel; Ophélie Cosnefroy; Marie-Line Andreola; Michel Ventura; Laura Tarrago-Litvak; Thérèse Astier-Gin
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

10.  High-throughput sequence analysis reveals structural diversity and improved potency among RNA inhibitors of HIV reverse transcriptase.

Authors:  Mark A Ditzler; Margaret J Lange; Debojit Bose; Christopher A Bottoms; Katherine F Virkler; Andrew W Sawyer; Angela S Whatley; William Spollen; Scott A Givan; Donald H Burke
Journal:  Nucleic Acids Res       Date:  2012-12-14       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.